Rune Labs, a startup based in San Francisco, USA has received clearance from the Food and Drug Administration (FDA) of the United States for the purpose of using the Apple Watch for monitoring the tremors and several other common symptoms in the patients with the Parkinson’s disease.
The software of Rune Labs uses the motion sensors built into the Apple Watch that can already be used for the purpose of detecting when a person falls. In an interview, Brian Pepin, chief executive of Rune Labs said, Apple Watch data is going to be combined with the data from the other sources, which is also including a Medtronic Inc. implant that is responsible for measuring the brain signals.
The goal of Rune Labs is for the doctors to use the combined data for the purpose of deciding whether and how to fine-tune the treatment of the patients and currently, chief executive said, most of the doctors will have to collect data on the movements of a patient by observing them during a short and clinical visit, which has not been ideal because the symptoms of Parkinson’s can widely vary over the time.
He said, by using the Apple Watch, the StrivePD software platform of Rune Lab is going to provide the doctors a continuous stream of observations over the long stretches and when thinking about the process of getting some to the optimal therapy, it has been a very decision for making when the doctors only have a little context.